Ifeanyichukwu Ifechidere: Coagulation Knowledge in Cardiology
Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals, shared on LinkedIn:
“In cardiology, anticoagulation is not simply about preventing clots.
It is about constantly balancing thrombosis against bleeding.
Consider a patient with atrial fibrillation.
Their stroke risk may make anticoagulation essential—but that does not mean the safest approach is automatically to prescribe an anticoagulant and move on.
The same principle applies across cardiovascular medicine:
Atrial fibrillation
Assess thromboembolic risk and bleeding risk before deciding on oral anticoagulation. The goal is stroke prevention without exposing the patient to unnecessary bleeding.
Acute myocardial infarction
Antiplatelet therapy is fundamental to preventing recurrent coronary thrombosis, particularly around PCI. But combining antiplatelet and anticoagulant therapies can substantially increase bleeding risk.
Valvular heart disease
The valve matters. Mechanical valves require lifelong anticoagulation, while other valvular conditions have different thromboembolic and antithrombotic considerations.
Heart failure
Heart failure alone does not automatically mean a patient needs anticoagulation. The indication should come from the underlying thromboembolic risk – such as atrial fibrillation, ventricular thrombus, or another established indication.
The real skill is knowing what not to prescribe.
- What am I trying to prevent?
- Stroke? Coronary thrombosis? Valve thrombosis? VTE?
- Does this patient actually have an indication?
- Is anticoagulation, antiplatelet therapy, or both required?
- What is the patient’s bleeding risk?
- Can I minimise the duration and intensity of combination therapy?
- Have renal function, age, drug interactions, previous bleeding and adherence been considered?
The most sophisticated antithrombotic strategy is not the one with the most medications.
It is the one that achieves the maximum protection with the minimum avoidable harm.
In cardiology, coagulation knowledge is therefore not just pharmacology.
It is risk stratification, clinical judgement, and continuous reassessment.
Prevent the clot. Respect the bleed. Reassess the balance.”
Stay updated with Hemostasis Today.
-
Aug 25, 2026, 13:30Danny Hsu: AIMS 2026 to Spotlight Differential Diagnosis of Thrombotic Microangiopathy
-
Aug 25, 2026, 12:26Rahaf M. Altahan: Diagnosis and Management of Factor XIII Deficiency
-
Aug 25, 2026, 12:20Christodoulos Papadopoulos: Oral Anticoagulation Monotherapy in Chronic Coronary Syndrome
-
Aug 25, 2026, 12:14Annie Bauzon: Platelets – The Tiny Cells That Stop You From Bleeding
-
Aug 25, 2026, 12:10Marloes de Kovel: FVIII Exposure With Severe Haemophilia A on Emicizumab Prophylaxis
-
Aug 25, 2026, 11:59What Happens When the Next Generation of Hematologists Looks Elsewhere? – Global Hemophilia Report
-
Aug 25, 2026, 11:54Kimberly Jacobson: MSL Opportunity in Rare Blood and Bleeding Disorders
-
Aug 25, 2026, 11:48GPAS 2026 Advancing Access and Equity in Bleeding Disorders – WFH
-
Aug 25, 2026, 11:41Gregory Lip: Don’t Miss – €1,000 Mechanical Thrombectomy Grant